Risky feelings: Why a 6% risk of cancer does not always feel like 6%

被引:69
|
作者
Zikmund-Fisher, Brian J. [1 ,2 ,3 ]
Fagerlin, Angela [2 ,3 ,4 ]
Ubel, Peter A. [2 ,3 ,4 ,5 ]
机构
[1] Univ Michigan, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Gen Med, Dept Internal Med, Ann Arbor, MI 48109 USA
[3] Ctr Behav & Decis Sci Med, Ann Arbor, MI USA
[4] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Practice Management &, Ann Arbor, MI USA
[5] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA
关键词
Risk communication; Decision making; Patient education; HEALTH-CARE DECISIONS; BREAST-CANCER; PREFERENCE REVERSALS; SEPARATE EVALUATIONS; RANDOMIZED-TRIAL; SURVIVAL GRAPHS; FAMILY-HISTORY; NUMERACY SCALE; OVARIAN-CANCER; INFORMATION;
D O I
10.1016/j.pec.2010.07.041
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: Emotion plays a strong role in the perception of risk information but is frequently underemphasized in the decision-making and communication literature. We sought to discuss and put into context several lines of research that have explored the links between emotion and risk perceptions. Methods: In this article, we provide a focused, "state of the science" review of research revealing the ways that emotion, or affect, influences people's cancer-related decisions. We identify illustrative experimental research studies that demonstrate the role of affect in people's estimates of cancer risk, their decisions between different cancer treatments, their perceptions of the chance of cancer recurrence, and their reactions to different methods of presenting risk information. Results: These studies show that people have strong affective reactions to cancer risk information and that the way risk information is presented often determines the emotional gist people take away from such communications. Conclusion: Cancer researchers, educators and oncologists need to be aware that emotions are often more influential in decision making about cancer treatments and prevention behaviors than factual knowledge is. Practice implications: Anticipating and assessing affective reactions is an essential step in the evaluation and improvement of cancer risk communications. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S87 / S93
页数:7
相关论文
共 50 条
  • [31] ACTL6A (Actin-like Protein 6A) enhances the cancer phenotype.
    Shrestha, Suruchi
    Adhikary, Gautam
    Xu, Wen
    Kandaysamy, Sivaveera
    Eckert, Richard L.
    CANCER RESEARCH, 2021, 81 (13)
  • [32] "I didn't feel like I could trust her and that felt really risky": a phenomenographic exploration of how Australian Midwives describe intrapartum risk
    Gabriel, Laura
    Reed, Rachel
    Broadbent, Marc
    Hastie, Carolyn
    MIDWIFERY, 2023, 118
  • [33] Dietary omega 3 (ω-3) & omega 6 (ω-6) PUFA consumption & ω-6/ω-3 in women at risk for breast cancer.
    Bridger, S
    Lewis, N
    Boeckner, L
    Guest, J
    FASEB JOURNAL, 1998, 12 (04): : A530 - A530
  • [34] Why does Supragingival calculus form preferentially on the lingual surface of the 6 lower anterior teeth?
    Dawes, Colin
    JOURNAL OF THE CANADIAN DENTAL ASSOCIATION, 2006, 72 (10): : 923 - 926
  • [35] Why Does Substitution of Thymine by 6-Ethynylpyridone Increase the Thermostability of DNA Double Helices?
    Halder, Antarip
    Datta, Ayan
    Bhattacharyya, Dhananjay
    Mitra, Abhijit
    JOURNAL OF PHYSICAL CHEMISTRY B, 2014, 118 (24): : 6586 - 6596
  • [36] Does Smad6 methylation control BMP signaling in cancer?
    Xu, Jian
    Derynck, Rik
    CELL CYCLE, 2014, 13 (08) : 1209 - 1210
  • [37] Why aren't there any trioxygenyl or ozonium salts?: Or, why does our reaction of O3 and PtF6 give O2PtF6?
    Liebman, JF
    Paige, HL
    Passmore, J
    STRUCTURAL CHEMISTRY, 1998, 9 (05) : 315 - 317
  • [38] Why Aren't There Any Trioxygenyl or Ozonium Salts? Or, Why Does Our Reaction of O3 and PtF6 Give O2PtF6?
    Joel F. Liebman
    Harvey L. Paige
    Jack Passmore
    Structural Chemistry, 1998, 9 : 315 - 317
  • [39] IL-6-like cytokines and cancer cachexiaConsequences of chronic inflammation
    Beverly E. Barton
    Immunologic Research, 2001, 23 : 41 - 58
  • [40] IL-6 Genomic Variants and Risk of Prostate Cancer
    Taheri, Mohammad
    Noroozi, Rezvan
    Rakhshan, Azadeh
    Ghanbari, Molud
    Omrani, Mir Davood
    Ghafouri-Fard, Soudeh
    UROLOGY JOURNAL, 2019, 16 (05) : 463 - 468